CAMERON ADELMAN: Open Payments
NPI 1871287672 · PROVIDENCE, RI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$159 in 6 payments from 6 companies in 2025. Trend: 2023 $110 · 2024 $213 · 2025 $159
Food & beverage: $159
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $34 |
| Astellas Pharma US Inc | 1 | $32 |
| ABBVIE INC. | 1 | $30 |
| AstraZeneca Pharmaceuticals LP | 1 | $26 |
| TOLMAR, INC. | 1 | $24 |
| Organon LLC | 1 | $13 |
Products named: Kerendia, Veozah, VRAYLAR, FARXIGA, FENSOLVI, NEXPLANON.
Industry payments across RI — which companies pay providers there.
